Medicine and Dentistry
Neuroendocrine Carcinoma
100%
Meta-Analysis
40%
Neck
29%
Larynx
26%
Wart Virus
23%
Carcinoid
22%
Surgery
22%
Open Surgery
20%
Minimally Invasive Surgery
20%
Laryngotracheal Stenosis
20%
Linezolid
20%
Mycobacterium Tuberculosis
20%
Disease Specific Survival
19%
Sinonasal Undifferentiated Carcinoma
18%
Radiation Therapy
17%
Neoplasm
15%
Isoniazid
13%
Neuroendocrine Differentiation
10%
Carcinoma
10%
Recurrent Disease
9%
Squamous Cell Carcinoma
9%
Small-Cell Carcinoma
8%
Large Cell Neuroendocrine Carcinoma
8%
Stenosis
8%
Tracheotomy
8%
Peak Expiratory Flow
8%
Chemoradiotherapy
7%
Extensively Drug Resistant Tuberculosis
6%
Ethambutol
6%
Rifampicin
6%
Streptomycin
6%
Patient Referral
6%
Head and Neck Cancer
6%
Cancer Staging
5%
Human Papillomavirus Type 6
5%
Pharmacology, Toxicology and Pharmaceutical Science
Neuroendocrine Carcinoma
80%
Mycobacterium Tuberculosis
42%
Human Papillomavirus
23%
Carcinoid
22%
Linezolid
20%
Virtual Screening
20%
Synthetase
20%
Methyldienolone
20%
Xylulose
20%
Capreomycin
20%
Erythritol
20%
Amikacin
20%
Kanamycin
20%
Disease Specific Survival
19%
Isoniazid
13%
Anaplastic Carcinoma
11%
Squamous Cell Carcinoma
9%
Small Cell Carcinoma
8%
Large Cell Neuroendocrine Carcinoma
8%
Rifampicin
6%
Streptomycin
6%
Ethambutol
6%
Extensively Drug-Resistant Tuberculosis
6%
Head and Neck Cancer
6%
Cancer Staging
5%
Chemotherapy
5%
Neoplasm
5%
Binding Site
5%
Human Papillomavirus Type 6
5%
Pharmacokinetics
5%
Keyphrases
Sinonasal Neuroendocrine Carcinoma
40%
Finding Balance
20%
Meta-analysis
20%
Differentiation Grade
20%
Laryngeal Neuroendocrine Carcinoma
20%
Capreomycin
20%
Treatment Strategy
20%
PNU-100480
20%
Small Cell Neuroendocrine Carcinoma
12%
Disease-specific Survival
11%
Sinonasal Squamous Cell Carcinoma (SNSCC)
11%
Survival Prediction
11%
Typical Carcinoid
10%
Radiotherapy
8%
Small Cell Carcinoma
8%
HPV6
5%
Chemotherapy
5%
Limited Value
5%
MGIT 960
5%
